DOI 10.1016/j.isci.2026.117696
Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma.
Аннотация
Cisplatin remains the primary chemotherapy drug for the treatment of head and neck squamous cell carcinoma (HNSCC). However, acquired resistance significantly limits its clinical application, contributing to treatment failure and a poor patient prognosis. Cancer-associated fibroblasts (CAFs) in the tumor microenvironment influence HNSCC sensitivity to cisplatin by modulating tumor cell responsiveness to treatment via paracrine signaling. CAFs impede deep penetration into tumors by remodeling the extracellular matrix (ECM). Various subtypes of cisplatin-resistant CAFs have been identified in HNSCC. Potential compounds targeting these subtypes could enhance cisplatin sensitivity. Simulation of the dynamic tumor microenvironment remains limited in research, hindering clinical translation. Bioinformatics has shifted research into cisplatin resistance in HNSCC. Single-cell sequencing and spatiotemporal transcriptomics could analyze the molecular profiles of CAFs that promote drug resistance in greater depth, potentially facilitating the development of highly targeted drugs and effective combination therapy strategies to overcome cisplatin resistance in HNSCCs.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.